Actinium Pharmaceuticals, Inc.
NYSE · Healthcare · Pharmaceutical Preparations · New York, NY
ATNM chart
What traders are saying about $ATNM
Latest postsActinium Pharmaceuticals, Inc. news
- Actinium Pharmaceuticals, Inc. (ATNM) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- ATNM: Introducing ATNM-400's HER3 Target
Yahoo Finance ·
- Actinium Pharmaceuticals brings oncology experts to new advisory board
Traders Union ·
- Actinium Pharmaceuticals forms scientific advisory board
Investing.com ·
- Actinium Pharmaceuticals forms five-member scientific advisory board
StreetInsider ·
- Actinium Pharmaceuticals Announces Formation of Scientific Advisory Board Featuring Leading Experts in Oncology and Radiopharmaceutical Development
Yahoo Finance ·
- Actinium Pharmaceuticals, Inc. (ATNM) Seasonal returns chart
Yahoo Finance UK ·
- Actinium Pharmaceuticals, Inc. (ATNM) stock price, news, quote and history
Yahoo Finance Australia ·
- Actinium Pharmaceuticals Unveils Three Iomab-ACT Studies for ASH 2026 Conference
Kalkine Media ·
- Actinium Pharmaceuticals to present Actimab-A safety and tolerability data at ASH26
Traders Union ·
- Actinium Pharmaceuticals Announces Three ASH 2026 Abstracts Highlighting Iomab-ACT Clinical Results in CAR T-Cell Therapy and Sickle Cell Disease
Yahoo Finance ·
- Actinium Pharmaceuticals Announces ASH 2026 Abstract Highlighting Long-Term Results of Actimab-A in Combination with CLAG-M in Relapsed or Refractory AML
Yahoo Finance ·
Actinium Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $90,000 | – | $81,000 | $1.0M |
| Net income | -$33.9M | -$38.2M | -$48.8M | -$33.0M |
| Diluted EPS | $-1.09 | $-1.27 | $-1.83 | $-1.37 |
| Total assets (year end) | $51.8M | $76.9M | $81.4M | $114.2M |
| Cash and equivalents (year end) | $48.0M | $72.9M | $76.7M | $108.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Actinium Pharmaceuticals, Inc.
- Ticker
- ATNM (NYSE)
- Industry
- Pharmaceutical Preparations
- Headquarters
- New York, NY
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1388320
- Former names
- Cactus Ventures, Inc.
Frequently asked questions
What exchange is Actinium Pharmaceuticals, Inc. listed on?
Actinium Pharmaceuticals, Inc. trades on the NYSE under the ticker symbol ATNM.
What industry is Actinium Pharmaceuticals, Inc. in?
Actinium Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Actinium Pharmaceuticals, Inc. headquartered?
Actinium Pharmaceuticals, Inc.'s business address on file with the SEC is in New York, NY.
When does Actinium Pharmaceuticals, Inc.'s fiscal year end?
Actinium Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Actinium Pharmaceuticals, Inc. report?
Actinium Pharmaceuticals, Inc. reported $90,000 in revenue for calendar year 2025, according to its SEC filings.